Alex Zhavoronkoff, Ph.D. is an expert in biotechnology and biophysics who has pioneered many initiatives to improve and extend senior health. He serves as director of both the Biogerontology Research Foundation and International Aging Research Portfolio, and heads NeuroG. Alex Zhavoronkov is the founder and CEO of Insilico Medicine, a company that utilizes AI for drug discovery and development, including applications in oncology.